YIELD10 BIOSCIENCE, INC.: Nasdaq/NYSE listing notice — Yield10 Bioscience receives final Nasdaq delisting notice; trading to OTC Markets May 16

YIELD10 BIOSCIENCE, INC.

Failed to maintain minimum stockholders' equity of $2.5M required by Nasdaq Listing Rule 5550(b)(1).
Nasdaq trading suspended at open on May 16, 2024; shares will trade on OTC Markets under symbol YTEN.
Company does not plan to appeal the delisting determination by the Nasdaq Hearings Panel.
Business operations expected unaffected; company exploring strategic opportunities including Camelina development.

item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

YIELD10 BIOSCIENCE, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

e Commission (“SEC”), which would remove the Company’s common stock from listing and registration on Nasdaq. As previously reported, on May 18, 2023, the Staff of the Nasdaq informed the Company that it did not comply with the minimum stockholders’ equity requirement pursuant to Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”). The Staff granted the Company’s request for an extension until September 30, 2023, which was subsequently extended until November 14, 2023, to comply with Rule 5550(b)(1). On November 15, 2023, we received a notice from Nasdaq of the Staff’s deter

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-24-061645

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.